Concepedia

N. Harbeck

NH

Statistics

Publications

2

Citations

22

H-Index

2

Active since

2025

Affiliations

Ulsan College(Current)

University of Ulsan

Vall d'Hebron Institute of Oncology

Vall d'Hebron Hospital Universitari

European Institute of Oncology

N. Harbeck is an author at Ulsan College specializing in oncology pharmacotherapy, cancer pharmacology, and breast cancer chemotherapy.

Publications per year

2025–2025

2

Publications

2

291O DESTINY-Breast11: Neoadjuvant trastuzumab deruxtecan alone (T-DXd) or followed by paclitaxel + trastuzumab + pertuzumab (T-DXd-THP) vs SOC for high-risk HER2+ early breast cancer (eBC)

N. Harbeck, S. Modi, L. Pusztai et al. · Annals of Oncology · 2025 · 12 citations

, , +14

Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial

Komal Jhaveri, Patrick Neven, M.L. Casalnuovo et al. · Annals of Oncology · 2025 · 10 citations · Full text

, , +10

1–2 of 2